RDGL
SHORT CANDIDATEMeanRevComposite
31.30
Technical
31.40
Fundamental
31.20
Rank
—
Price
0.06
Hurst
0.36
As of
Jul 16, 2026
Daily
Vivos Inc.
HealthcareMedical DevicesVivos Inc. is a radiation oncology company developing yttrium-90-based medical devices for treating inoperable tumors. The company's lead product, RadioGel, is an injectable gel designed to deliver precision radionuclide therapy to cancerous tumors in humans and animals, while IsoPet targets solid tumors in animals. The company is also working on polymer platforms and laboratory equipment for drug delivery and thermal applications across several product lines.
Market cap
$23.7M
P/E (trailing)
—
P/E (forward)
—
PEG ratio
—
Dividend yield
—
Beta
-0.72
52w range
0.04 – 0.12
Return on equity
-132.51%
Profit margin
0.00%
Revenue growth
+142.70%
Earnings growth
—
Price history
1Y: 0.05 (-48.6%) · range 0.05–0.09
Cycle position
12/ 100 cycle scoreENTRY ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 74 · GOOD SETUP · exit proximity 0
Conviction
50/ 100 · maturity 14%
VScore.0916
Buildup.3044
EMA entry setup.3874
Fundamentals.2331
Volume profile
POC
0.07
Price vs POC
-31.0%
Overhead supply
98%
Runway
+44.9%
Value area 0.05–0.07 · 98% of 120d volume overhead · heavy supply
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| insider-activity | 0.281 | Sep 17, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -11.22% | +0.34% | 3/20d |
| 40d | -11.22% | +0.34% | 3/40d |